Effects of MDMA, MDA and MDEA on Blood Pressure, Heart Rate, Locomotor Activity and Body Temperature in the Rat Involve Alpha-adrenoceptors

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2006 Feb 24

PMID 16491100

Citations 26

Authors

Sotiria Bexis

James R Docherty

Affiliations

Soon will be listed here.

Abstract

The effects of injection of 3,4-methylenedioxymethamphetamine (MDMA), 3,4-methylenedioxyamphetamine (MDA) and N-ethyl-3,4-methylenedioxyamphetamine (MDEA) (all 20 mg kg(-1)) on blood pressure, heart rate, core body temperature and locomotor activity in conscious rats were investigated using radiotelemetry. MDMA and MDA produced a prolonged increase in both systolic and diastolic pressures, with MDA causing the most marked rise. MDEA produced a transient but nonsignificant fall in diastolic pressure. The pressor response produced by MDA was accompanied by bradycardia. All three amphetamine derivatives caused an initial hypothermic response; however, MDA also produced a subsequent hyperthermia, and the speed of recovery from hypothermia was MDA>MDMA>MDEA. The alpha2A-adrenoceptor antagonist 2-((4,5-dihydro-1H-imidazol-2-yl)methyl)-2,3-dihydro-1-methyl-1H-isoindole (BRL 44408) (1 mg kg(-1)) prolonged the hypothermic response to MDMA. Only MDA induced locomotor activity when given alone, but in the presence of BRL 44408, MDMA produced increased locomotor activity. The order of potency for producing isometric contractions of rat aorta (alpha1D) and vas deferens (alpha1A) was MDA>MDMA>MDEA, with MDEA acting as an alpha1-adrenoceptor antagonist with a pK(B) of 4.79+/-0.12 (n = 4) in aorta. The order of potency for prejunctional inhibition of stimulation-evoked contractions in rat vas deferens (alpha2A-adrenoceptor mediated) was MDA>MDMA>MDEA. Blood pressure actions of the three amphetamine derivatives may be at least partly due to alpha1-adrenoceptor agonism or antagonism. The reversal of the hypothermic actions are at least partly due to alpha2A-adrenoceptor agonism since the hypothermic response was more prolonged with MDEA which exhibits low alpha2A-adrenoceptor potency, and effects of MDMA after alpha2A-adrenoceptor antagonism were similar to those of MDEA.

Citing Articles

Assessment of a Single Quadrupole Mass Spectrometer Combined with an Atmospheric Solids Analysis Probe for the On-Site Identification of Amnesty Bin Drugs.

Frinculescu A, Mercer B, Shine T, Ramsey J, Couchman L, Douce D J Am Soc Mass Spectrom. 2024; 35(7):1480-1489.

PMID: 38837752 PMC: 11228975. DOI: 10.1021/jasms.4c00064.

Behavioral metabolomics: how behavioral data can guide metabolomics research on neuropsychiatric disorders.

van de Wetering R, Vorster J, Geyrhofer S, Harvey J, Keyzers R, Schenk S Metabolomics. 2023; 19(8):69.

PMID: 37530897 PMC: 10397151. DOI: 10.1007/s11306-023-02034-6.

Locomotor effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in mice: psychostimulant effects, stereotypy, and sensitization.

Berquist M, Leth-Petersen S, Kristensen J, Fantegrossi W Psychopharmacology (Berl). 2019; 237(2):431-442.

PMID: 31729537 PMC: 7388080. DOI: 10.1007/s00213-019-05380-3.

Differential physiological changes following internet exposure in higher and lower problematic internet users.

Reed P, Romano M, Re F, Roaro A, Osborne L, Vigano C PLoS One. 2017; 12(5):e0178480.

PMID: 28542470 PMC: 5444838. DOI: 10.1371/journal.pone.0178480.

Ecstasy (MDMA) Alters Cardiac Gene Expression and DNA Methylation: Implications for Circadian Rhythm Dysfunction in the Heart.

Koczor C, Ludlow I, Hight 2nd R, Jiao Z, Fields E, Ludaway T Toxicol Sci. 2015; 148(1):183-91.

PMID: 26251327 PMC: 4731408. DOI: 10.1093/toxsci/kfv170.

References

Cheng Y, Prusoff W . Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973; 22(23):3099-108. DOI: 10.1016/0006-2952(73)90196-2. View

Sprague J, Brutcher R, Mills E, Caden D, Rusyniak D . Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with alpha1- plus beta3-adrenoreceptor antagonists. Br J Pharmacol. 2004; 142(4):667-70. PMC: 1575043. DOI: 10.1038/sj.bjp.0705823. View

Hayner G, McKinney H . MDMA. The dark side of ecstasy. J Psychoactive Drugs. 1986; 18(4):341-7. DOI: 10.1080/02791072.1986.10472367. View

GOLD L, Koob G, Geyer M . Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats. J Pharmacol Exp Ther. 1988; 247(2):547-55. View

Young P, Berge J, Chapman H, Cawthorne M . Novel alpha 2-adrenoceptor antagonists show selectivity for alpha 2A- and alpha 2B-adrenoceptor subtypes. Eur J Pharmacol. 1989; 168(3):381-6. DOI: 10.1016/0014-2999(89)90801-7. View

Lavelle A, Honner V, Docherty J . Investigation of the prejunctional alpha2-adrenoceptor mediated actions of MDMA in rat atrium and vas deferens. Br J Pharmacol. 1999; 128(5):975-80. PMC: 1571719. DOI: 10.1038/sj.bjp.0702875. View

de la Torre R, Farre M, Ortuno J, Mas M, Brenneisen R, Roset P . Non-linear pharmacokinetics of MDMA ('ecstasy') in humans. Br J Clin Pharmacol. 2000; 49(2):104-9. PMC: 2014905. DOI: 10.1046/j.1365-2125.2000.00121.x. View

Cryan J, Harkin A, Naughton M, Kelly J, Leonard B . Characterization of D-fenfluramine-induced hypothermia: evidence for multiple sites of action. Eur J Pharmacol. 2000; 390(3):275-85. DOI: 10.1016/s0014-2999(00)00012-1. View

Sugimoto Y, Ohkura M, Inoue K, Yamada J . Involvement of the 5-HT(2) receptor in hyperthermia induced by p-chloroamphetamine, a serotonin-releasing drug in mice. Eur J Pharmacol. 2000; 403(3):225-8. DOI: 10.1016/s0014-2999(00)00585-9. View

10.

OCain P, Hletko S, Ogden B, Varner K . Cardiovascular and sympathetic responses and reflex changes elicited by MDMA. Physiol Behav. 2000; 70(1-2):141-8. DOI: 10.1016/s0031-9384(00)00235-3. View

11.

Daws L, Irvine R, Callaghan P, Toop N, White J, Bochner F . Differential behavioural and neurochemical effects of para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine in the rat. Prog Neuropsychopharmacol Biol Psychiatry. 2000; 24(6):955-77. DOI: 10.1016/s0278-5846(00)00113-5. View

12.

Bankson M, Cunningham K . 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions. J Pharmacol Exp Ther. 2001; 297(3):846-52. View

13.

Guimaraes S, Moura D . Vascular adrenoceptors: an update. Pharmacol Rev. 2001; 53(2):319-56. View

14.

OLoinsigh E, Boland G, Kelly J, OBoyle K . Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat. Prog Neuropsychopharmacol Biol Psychiatry. 2001; 25(3):621-38. DOI: 10.1016/s0278-5846(00)00179-2. View

15.

McDaid J, Docherty J . Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat. Br J Pharmacol. 2001; 133(3):429-37. PMC: 1572800. DOI: 10.1038/sj.bjp.0704094. View

16.

Ahmad H, Kheradmand F, Connolly C, Docherty J . Effects of methylenedioxymethamphetamine on noradrenaline-evoked contractions of rat right ventricle and small mesenteric artery. Eur J Pharmacol. 2001; 422(1-3):169-74. DOI: 10.1016/s0014-2999(01)01070-6. View

17.

Boules M, Warrington L, Fauq A, McCormick D, Richelson E . A novel neurotensin analog blocks cocaine- and D-amphetamine-induced hyperactivity. Eur J Pharmacol. 2001; 426(1-2):73-6. DOI: 10.1016/s0014-2999(01)01197-9. View

18.

Ghuran A, van der Wieken L, Nolan J . Cardiovascular complications of recreational drugs. BMJ. 2001; 323(7311):464-6. PMC: 1121066. DOI: 10.1136/bmj.323.7311.464. View

19.

Pedersen N, Blessing W . Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits. J Neurosci. 2001; 21(21):8648-54. PMC: 6762811. View

20.

Sugimoto Y, Ohkura M, Inoue K, Yamada J . Involvement of serotonergic and dopaminergic mechanisms in hyperthermia induced by a serotonin-releasing drug, p-chloroamphetamine in mice. Eur J Pharmacol. 2001; 430(2-3):265-8. DOI: 10.1016/s0014-2999(01)01386-3. View